Indolent B Cell Lymphoma
7 clinical trials · Condition
◉ Watch Indolent B Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL (NCT03019666) | Masonic Cancer Center, University of Minnesota | 2017-10-18 |
| p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies (NCT02846935) | Yogen Saunthararajah | 2017-04-25 |
| Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection (NCT02836925) | Fondazione Italiana Linfomi - ETS | 2016-03-01 |
| A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies (NCT01805375) | Cancer Research UK | 2013-04-01 |
| High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas (NCT00895661) | Massachusetts General Hospital | 2009-07-01 |
Track Indolent B Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.